Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ArriVent Biopharma, Inc. | President and CEO, Director | Common Stock | 394K | $1.44M | $3.65 | Jan 25, 2024 | Held by The MAKS Yao Trust |
ArriVent Biopharma, Inc. | President and CEO, Director | Common Stock | 219K | $798K | $3.65 | Jan 25, 2024 | Held by ArriMed BioPharma, LLC |
ALUMIS INC. | Director | Common Stock | 23.5K | $376K | $16.00 | Jul 1, 2024 | Direct |
NexImmune, Inc. | Director | Stock Option (right to buy) | 45K | Jul 5, 2023 | Direct | ||
ALUMIS INC. | Director | Stock Option (Right to Buy) | 4.28K | Jul 1, 2024 | Direct | ||
ALUMIS INC. | Director | Class A Common Stock | 0 | Jul 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALMS | ALUMIS INC. | Jun 27, 2024 | 7 | $0 | 4 | Jul 1, 2024 | Director |
ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | Director |
AVBP | ArriVent Biopharma, Inc. | Jan 25, 2024 | 0 | $0 | 3 | Jan 25, 2024 | President and CEO, Director |
NEXI | NexImmune, Inc. | Jul 5, 2023 | 1 | $0 | 4 | Jul 7, 2023 | Director |
NEXI | NexImmune, Inc. | Apr 4, 2023 | 6 | $0 | 4 | Apr 6, 2023 | Director |
NEXI | NexImmune, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |